Skip to main content
Quest Diagnostics

Concordance of Phosphatidylserine/Prothrombin and APhLTM Antibodies Associated With Antiphospholipid Syndrome–Associated Pregnancy Morbidity

International Society on Thrombosis and Haemostasis 31st Congress

ISTH 2023

Montreal, Canada, June 24-28, 2023

Poster presentation: Concordance of Phosphatidylserine/Prothrombin and APhLTM Antibodies Associated With Antiphospholipid Syndrome–Associated Pregnancy Morbidity

Authors: Wong ECC, Espinoza A, Worfolk LA

Specialty: Oncology, Hematology, Coagulation, Hemostasis, Womens Health, OB/GYN

Related content

Publication
Atypical presentation of pediatric antiphospholipid syndrome
Conference Presentation
Evaluation of Heparin-induced Thrombocytopenia Before and during the COVID-19 Pandemic at a US National Reference Laboratory
Test FAQ
Anti PF4 and Serotonin Release Assay SRA for Diagnosing Heparin induced Thrombocytopenia Thrombosis HIT HITT
Test FAQ
Antiphospholipid Antibodies
Test FAQ
Phosphatidylserine-Prothrombin Antibodies, IgG, IgM
Test FAQ
Prothrombin Time With INR

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.